TEM
Tempus AI, Inc. Class A Common Stock
Mentions (24Hr)
100.00% Today
Reddit Posts
Mentions
I'm officially bagholding TEMP and regret not selling when i was up 15% The amount of insider selling in the last 6 months is wild. [https://finviz.com/quote.ashx?t=TEM&p=d](https://finviz.com/quote.ashx?t=TEM&p=d) Scroll all the way down.
haven't followed TEM closely enough to have a strong take, but the "dropped on good earnings" setup is always tricky because sometimes the market is pricing in something you're not seeing yet.
Didn’t Pelosi sell most of her positions in TEM.
I’ve been eyeing TEM. Mostly because Pelosi bought. Not sure if it is a super awesome value.
Ok. I was right about getting that CAVA call, sadly I sold it before close....so my put position is dust lol. TEM seems ok though.
she got TEM at 80, PINS at 27 Lol
TEM calls into earnings tonight
TEM calls into earnings tonight
Snow, CRM, SNPS, WDAY, CAVA, TEM
TEM earnings after hours. What are we guessing up or down
OXY was a nice pickup. I think it has some room to climb and TEM will soar on earnings bc it's gonna recap their year and announce the moneys expected from Europe launch
TEM calls.. Nancy doesn’t lose
Put rest of money in TEM. It's made me a lot of money over the past year
Been thinking of starting a $TEM position - seems like a great buy here at $50~
I just bought a shitload of cheapass TEM calls. Just because Pelosi bought calls last year and exercised them.
I have a feeling TEM is going to jump quickly
TEM turn darker green, my calls are down like 80¢
I don’t track her portfolio as a whole. I’ve been following the SEC filings of her recent stock purchases within the last 2-3 years. They all made a killing since date of purchase. I believe Google was this year, TEM, VST last year, PANW the year before. Also think she got in early on NVDA 2 years ago
Lets recount the "dips" ive bought over the months and what ended up happening: TEM: bought 50 shares at $70 after it came down 5% in a day, it proceeded to drop to $50 and hove between $50 and $60 for 3 months, one random day, it shot up to $75 and I sold vowing never to touch that stock again. NBIS: bought 50 shares after it fell from $140 to $115, it continued to where its at now and im still holding. HOOD: bought 10 shares on friday seeing a decent dip, bought 10 more on monday, then 20 earlier today. Im starting to realize im whats wrong in this pattern.
Here is how Cathie Woods largest holdings performed in January 2026 Tesla $TSLA -4.3%🔴 Crispr $CRSP -4.7%🔴 $ROKU -12.3%🔴 Tempus AI $TEM +1.3%🟢 Coinbase $COIN -13.9%🔴 Shopify $SHOP -18.5%🔴 $AMD +10.5%🟢 Robinhood $HOOD -12%🔴 $BEAM -0.3%🔴 Teradyne $TER +24.5%🟢
Reminds me of when I tried to buy puts on OKLO… TEM…. Damn near the peak in October but about 2-3 weeks early.
You forget $TEM Tempus AI options exercised
She sold Paypal She is long NVDA GOOG AMZN TEM VST
Nancy bought more TEM? Crazy
33% ALAB, 33% TEM, 33% PL, 1% Poet
Companies that are based outside of the US will naturally trade at discounted PEs. I can give you countless examples of this: \- Sophia AI (US counterpart: TEM, CAI) \- BAE Systems (US counterpart: LMT, AVAV) \- Alibaba, Coupang (US counterpart: Amazon, Etsy)
IMO, RXRX is a very Cathie Wood stock. It conceptually sounds appealing/exciting theme but when you look at ARKG over the last 5 years, you can see the "hype years" and you can see the years where healthcare is struggling and fundamentals matter. In the latter (2021, 2022, 2024) , the fund has been at the bottom of the category. When you look at the long-term? 3YR/5YR/10YR the fund is at or near the bottom of the category. IMO, if you have one of the greatest growth investing periods that I've ever invested in and the 5 year chart is just a continual erosion, there's something amatter. Recursion merged with peer Exscientia in August 2024. If this was such a compelling area, why would that company sell itself way off the highs? The merger hasn't seemed to help RXRX either. In terms of trials: REC-994 (Cerebral Cavernous Malformation): Recursion's lead candidate failed to demonstrate convincing efficacy in Phase 2. While it met the primary goal of safety, long-term extension data showed no promising trends in MRI or functional outcomes, becoming indistinguishable from natural history. REC-2282 (Neurofibromatosis Type 2): Development was halted after preliminary Phase 2/3 data from the POPLAR-NF2 trial showed limited tumor shrinkage and clinical activity. While the 40mg dose passed a futility threshold, the totality of the data did not justify further investment. REC-3964 (C. difficile Infection): Despite being the first new chemical entity developed through the "RecursionOS" platform, this Phase 2 program was discontinued in May 2025. The company cited a strategic decision to focus on other areas rather than clinical setbacks. REC-4881 (Solid Tumors): A pause was announced for this drug specifically targeting solid tumors, though it remains in development for other indications like FAP (Familial Adenomatous Polyposis) where it has shown more positive results. The company has been around for a bit now and when you look at the pipeline, there is one thing in phase 2, nothing in phase 3, the rest are all phase 1/pre clinical. Looking at a discussion on r/biotech: "Think it came up in another thread, but they just don't give the vibe they know what they're doing in clinical development. It's hard to say it exactly. But somehow they don't talk like they understand how hard it is to actually get something to market and what needs to be done to make that happen." (https://www.reddit.com/r/biotech/comments/1f8icsi/with_few_specifics_recursion_underwhelms_with/ - another thread: https://www.reddit.com/r/biotech/comments/1klmsi1/what_do_you_guys_think_of_recursion/) Also, I wasn't even aware the CEO stepped down a couple mo ago. Again, not saying this is a zero and don't want to be harsh but I just think this is one of those things where the results haven't matched the hype. The stock is 33% short (which says something) so any good news and could get a short squeeze. There is some cash to get through the year and there is a pipeline, but nothing in that pipeline is in stage 3/is seeming to generate that much excitement. IMO, AI around genetic testing (TEM, GH, former ILMN spin off/source of controversy GRAL, NTRA) has been an investment theme that has delivered a lot more than AI drug discovery - at least at this point.
TEM - Tempus AI earnings were impressive. That was insane revenue growth. TEM could trade up to $100
$TEM going to $100, revenue grew big
Fuks going on with TEM?
TEM is going to absolutely pop tomorrow!
No Golden window as stocks can sell off and "crater" or spike up and "moon" at any time during the day. Many times, my order does not fill. If a stock is in a down (or up) trending channel and the order does not fill today, I may actually get a better premium 1 or 2 days later for the same expiration. Sometimes, I wait a week and end up with a great premium. I have zero problems in waiting for a better premium. Imagine a current premium yielding 5% APR and then 2-3days later yields 8% APR for the same strike & expiration. Is it worth it to wait if the technicals reveal the possibility of a better entry point? For me it is. Sometimes, I miss out due to greediness and I may end up taking a lower a premium, such as: day 1, premium is 5%. day 3, premium hits 8.5%, Day 7, premium hits 12%, and day 9 it hits 7%. I enter at 7% APR and missed several opportunities to get a better price than what I ended up with when I entered. My minimum goal is to always beat what a HYSA or what a CD would yield on an APR/APY basis. My money does not have to be tied up in some trade 24/7. So, I wait a few days and pick the spots I think are winners and will deliver that APR I am satisfied with. In 2025, I made 92 trades (86 were selling calls or puts and 5 bought calls). In selling Puts, the largest APR I made was on TEM. I sold the $43. strike (stock was at $43.72) on 1/21/25 with an expiration of 2/21/25 and collected $5.53 in premium off of $3747 of collateral. Two days later, I closed it out and kept $307. Your jaw would drop when you calculate the APR of return on that. About 40 of my trades are between 10% APR and 100% APR and about 30 are between 100% and 1000% APR. I took 1 loss on a sold call where I collected $760 in premium off of $2364 of collateral (on PLTR) with an expiration that was 66 days out. I had to pay $1448 to close it out early as I did not want to sell my shares. Since then, I've learned how to roll calls up & out if needed. I do not like to do that because you reduce your APR as you roll if the stock "takes off!"
Anyone going long on TEM? No more hookers for me I’m only investing this year.
\-6.24% YTD. I was actually **up 10%** at one point, but then I started **overtrading** in October. Got **hit hard** by HK stocks and TEM. Sticking to **megacaps** only next year—hoping for a comeback.
Right, these are Tempus AI earnings by quarter: [https://stockschecker.com/earnings?tab=Tab4&ticker=TEM](https://stockschecker.com/earnings?tab=Tab4&ticker=TEM)
Notionally true. Stock-go-up still worked at a macro level, it just changed the risk management strategy on a daily basis. I used to swing day trades for weeks prior to Feb, I recall having those TEM options for maybe 3 weeks...after March-April swings were death, every crash crushed premium prices across the board. It's no accident that investment banks made the biggest profits in their trading departments by Easter last year since 2008.
I think healthcare will make a comeback next year. HIMS TEM NVO for me
Why is TEM going up now?
I’m betting on HIMS TEM OKLO
thoughts on TEM for the next week?
I’m betting on HIMS SYM TEM OKLO
TEM major deal announcement coming. You set your reminders.
Put all your money in TEM
Friday TEM could be back to a $100 stock. Just watch.
TEM. Please. Load calls. Trust me bro.
Please. Buy as much TEM as you can. I can’t say why but it’s been a while my insider is giving me information. Buy TEM.
$TEM - AI stock that will get you rich
in january she bought contracts for $TEM so i loaded up on calls and it paid off. I don't know why people hate congress who does insider trading you can copy them 😂😂and yes I know the data is delayed but you can still get something good
Constellation Energy and Next Era Energy, I also picked up more NVDA, PLTR, TEM and ONDS this morning
MU CHOR TEM GOOG Meta some PLT and sofi for now
I bought PLTR、TEM、NBIS、CAI、ARM...
What do people think META DUOL TEM NVO. Any winners? I usually like to full port one stock since diversity is for cowards
Bookmarked a TEM monthly a monthly ago. $1,000 -> $100. Usually I’m a paper trading legend
This is a good price for TEM
Is TEM a buy at these levels....
Holy moly…. Nancy killed TEM 💃💃💃🤣
TEM on discount Shit is literally printing money and will continue to do so
TEM double beat, raises guidance, so naturally it's -10% AH
Good dip buying opportunity today. I bought: * $RDDT Feb'26 200 Call * $ETHA (Ethereum) * $BSOL (Solana) * $IBIT (Bitcoin) * $TEM (down 5% + extra 7% afterhours) * $AXON (down 20% afterhours) This is my biggest single day purchase since April market drop!
Yikes. TEM was horrendous. Confused at only -7
Like PLTR, both TEM and KTOS beat expectations and plummeted.
It’s okay, as long as I don’t look at my TEM calls. Just don’t look at them, just keep the ignorance.
TEM bot setting up good vibes for AMD
Gonna play TEM earnings and get my back blown out
$TEM - Tempus Ai will trade up to $100
Did research on current breakout candidates. IREN, AMGN, CRWV, ALB, TEM. You’re welcome, this is my one and only freebie for you morons
The following 11 days of earnings are going to define my year. SMCI 11/4. TEM 11/4. AMD 11/4. APP 11/5. HOOD 11/5. RKLB 11/10. CRWV 11/10. NBIS 11/11. CHYM 11/5. I own mostly shares and am doing well over the year, but that can all change over the next 11 days.
Yeah cool but that was the bottom for everything so you could have made about 10,000% more if you'd bough APLD or NBIS or GOOG or NVDA or AMD or TEM
What do people think of TEM? Thinking of full porting
#TLDR --- Ticker: CAI Direction: Up Prognosis: Buy $35c/$40c expiring Nov 21 Catalyst: Earnings on November 5. Competitor (TEM) reports the day before, which could signal sector strength. Diagnosis: CAI's AI-powered universal cancer test is faster and cheaper than competitors. Stock jumped ~30% on the last earnings beat, and OP is betting on a repeat performance.
Man, I’ve been trying to time a good entry for some stocks to invest in (UBER, TEM, CRWV?) but they’ve just been chopping around and are up so much this year. With this weeks tailwinds, I’m not sure if I’m going to get left in the dust and chasing or I should keep “waiting for the right dip”. Difficult knowing it’s hard to time and if I’m investing for long term I shouldn’t sweat entries, but damn I’m struggling with this one
VST and TEM ruining my fun as usual